Sharekhan

Global Health Ltd

Wed 16/07/2025,13:14:57 | NSE : MEDANTA

₹ 1343.1016.90 (1.27%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1332.90

Previous Close

₹ 1326.20

Volume

141292

Mkt Cap ( Rs. Cr)

₹36098.55

High

₹ 1348.50

Low

₹ 1330.10

52 Week High

₹ 1346.50

52 Week Low

₹ 935.50

Book Value Per Share

₹ 116.89

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Global Health Ltd

Your Vote -

Buy

38.10%

Hold

52.38%

Sell

9.52%

38.10%

42 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

34%

Sell Order Quantity

66%

Bid Price

Qty

1341.20

9

1341.00

478

1341.00

310

1341.00

2

1341.00

5

Bid Total

30716

Bid Price

Qty

1342.20

14

1342.00

24

1342.00

15

1342.00

9

1343.00

11

Bid Total

60722

Option Chain

Analyzes market sentiment, predicts Global Health Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Global Health - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    11 Jul 2025, 5:37PM Intimation under Regulation 30 of the Listing Regulations.
  • Global Health - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    11 Jul 2025, 5:22PM Global Health Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
  • Global Health - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2025, 3:29PM Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Global Health - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2025, 3:30PM Please find attached herewith the Certificates issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 by RTA for quar
  • Global Health - Trading Window-XBRL

    27 Jun 2025, 4:30PM GLOBAL HEALTH LIMITED has informed the Exchange about Closure of Trading Window
  • Global Health - Trading Window

    27 Jun 2025, 4:27PM Global Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20
  • Global Health - Alteration Of Capital and Fund Raising-XBRL

    26 Jun 2025, 6:45PM GLOBAL HEALTH LIMITED has informed the Exchange regarding Allotment of Securities
  • Global Health - ESOP/ESOS/ESPS

    26 Jun 2025, 6:39PM Global Health Limited has informed the Exchange regarding Allotment of 90000 Shares.
  • Global Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    26 Jun 2025, 6:27PM Intimation under Regulation 30 of Listing Regulation for Allotment of Equity Shares under the Global Health Limited - Employee Stock Option Scheme 201
  • Global Health - Disclosure under SEBI Takeover Regulations

    25 Jun 2025, 7:39PM Global Health Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substan
  • Global Health - Clarification - Financial Results

    23 Jun 2025, 12:37PM The Exchange has sought clarification from Global Health Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Jun 2025, 5:32PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Jun 2025, 5:33PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting.
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Jun 2025, 5:31PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Jun 2025, 6:04PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Jun 2025, 5:38PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Jun 2025, 5:34PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Jun 2025, 5:32PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Jun 2025, 1:13PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 Jun 2025, 1:17PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 Jun 2025, 1:15PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Jun 2025, 4:10PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Jun 2025, 4:06PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    27 May 2025, 10:52AM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 May 2025, 10:57AM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 May 2025, 10:56AM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 May 2025, 10:54AM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - General Updates

    23 May 2025, 2:14PM Global Health Limited has informed the Exchange regarding Declaration under Regulation 33 of SEBI Listing Regulation.
  • Global Health - Declaration Under Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    23 May 2025, 1:52PM Declaration under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    21 May 2025, 4:58PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    21 May 2025, 4:50PM Announcement under Regulation 30 of Listing Regulation for Earning Conference Call Transcript
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    21 May 2025, 4:50PM Global Health Limited has informed the Exchange about Transcript
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 May 2025, 4:59PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 May 2025, 4:57PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 May 2025, 4:56PM Intimation under Regulation 30 of Listing Regulation for Schedule of Analysts/Institutional Investors Meeting
  • Global Health - Announcement under Regulation 30 (LODR)-Investor Presentation

    16 May 2025, 8:40PM Intimation of revised Investor Presentation for fourth quarter and financial year ended March 31, 2025 results.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    16 May 2025, 8:37PM Global Health Limited has informed the Exchange about Presentation
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    16 May 2025, 8:32PM Global Health Limited has informed the Exchange about Link of Recording
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    16 May 2025, 8:31PM Intimation of Audio Recording for fourth quarter and financial year ended March 31, 2025 results.
  • Global Health - Copy of Newspaper Publication

    16 May 2025, 12:48PM Global Health Limited has informed the Exchange about Copy of Newspaper Publication
  • Global Health - Updates

    15 May 2025, 10:15PM Global Health Limited has informed the Exchange regarding 'Key Performance Indicators for FY 2024-25'.
  • Global Health - Key Performance Indicators (Kpis) For FY 2024-25

    15 May 2025, 10:10PM Pursuant to SEBI ICDR Regulations, please find the Key Performance Indicators for FY 2024-25
  • Global Health - Announcement under Regulation 30 (LODR)-Investor Presentation

    15 May 2025, 9:52PM Investor Presentation for the fourth quarter and financial year ended March 31, 2025
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    15 May 2025, 9:52PM Global Health Limited has informed the Exchange about Presentation
  • Global Health - Press Release

    15 May 2025, 9:40PM Global Health Limited has informed the Exchange regarding a press release dated May 15, 2025, titled ""Press Release"".
  • Global Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 May 2025, 9:39PM Press Release for the fourth quarter and year ended March 31, 2025 Results.
  • Global Health - Updates

    15 May 2025, 5:39PM Global Health Limited has informed the Exchange regarding 'Amendment in the Code of Conduct pursuant to the regulation 8 & 9 of SEBI (Prohibition of I
  • Global Health - Amendment In The Code Of Conduct Pursuant To Regulation 8 & 9 Of SEBI (Prohibition Of Insider Trading) Regul

    15 May 2025, 5:35PM Amendment in the Code of Conduct pursuant to Regulation 8 & 9 of SEBI (Prohibition of Insider Trading) Regulation, 2015
  • Global Health - Outcome of Board Meeting-XBRL

    15 May 2025, 5:14PM GLOBAL HEALTH LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 15-May-2025 for Dividend
  • Global Health - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    15 May 2025, 4:56PM GLOBAL HEALTH LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Global Health - Change in Management

    15 May 2025, 4:51PM Global Health Limited has informed the Exchange about change in Management
  • Global Health - Announcement under Regulation 30 (LODR)-Change in Management

    15 May 2025, 4:43PM Announcement regarding appointment of Dr. Pankaj Dhamija as one of the Senior Management Personnel.
  • Global Health - Announcement under Regulation 30 (LODR)-Dividend Updates

    15 May 2025, 4:38PM Intimation for outcome of Board meeting for recommending final dividend.
  • Global Health - Outcome of Board Meeting

    15 May 2025, 4:36PM Global Health Limited has informed the Exchange regarding Outcome of Board Meeting held on May 15, 2025.
  • Global Health - Dividend

    15 May 2025, 4:36PM Global Health Limited has informed the Exchange that Board of Directors at its meeting held on May 15, 2025, recommended Final Dividend of Rs. 0.50 pe
  • Global Health Q4 net profit up 1.27% at Rs 93.41 cr

    15 May 2025, 4:30PM The company reported standalone net profit of Rs 93.41 crore for the quarter ended March 31, 2025 as compared to Rs 92.24 crore in the same period las
  • Global Health - Results For The Quarter And Financial Year Ended March 31, 2025

    15 May 2025, 4:29PM Results for the Quarter and Financial year ended March 31, 2025
  • Global Health - Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI Listing Regulation

    15 May 2025, 4:21PM Outcome for Board Meeting held today for approving Audited Financials and recommending Final Dividend.
  • Global Health - ESOP/ESOS/ESPS

    15 May 2025, 11:23AM Global Health Limited has informed the Exchange regarding Grant of 10000 Options under GHL LTIP Plan 2024.
  • Global Health - ESOP/ESOS/ESPS

    15 May 2025, 11:18AM Global Health Limited has informed the Exchange regarding Allotment of 73000 Shares under GHL LTIP Plan 2024.
  • Global Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    15 May 2025, 11:13AM Intimation under Regulation 30 of SEBI Listing Regulation regarding Allotment of Shares.
  • Global Health - Alteration Of Capital and Fund Raising-XBRL

    15 May 2025, 11:10AM GLOBAL HEALTH LIMITED has informed the Exchange regarding Allotment of Securities
  • Global Health - Committee Meeting Updates

    15 May 2025, 11:04AM Global Health Limited has informed the Exchange regarding Outcome of Nomination & Remuneration Committee Meeting held on May 15, 2025.
  • Global Health - Announcement under Regulation 30 (LODR)-Meeting Updates

    15 May 2025, 11:02AM Outcome of Nomination and Remuneration Committee Meeting regarding Allotment of Shares and Grant of options.
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 May 2025, 12:45PM Intimation for Earnings Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    9 May 2025, 12:45PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Board Meeting Intimation

    5 May 2025, 11:54AM GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 15-May-2025 to consider and approve the Yearly Audited Financial res
  • Global Health - Board Meeting Intimation for Board Meeting Intimation Regarding Approval Of Financial Results For The Quarter

    5 May 2025, 11:37AM Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and ap
  • Global Health - Press Release

    28 Apr 2025, 2:55PM Global Health Limited has informed the Exchange regarding a press release dated April 28, 2025, titled ""This press release is regarding purchase of l
  • Global Health - Capacity addition

    28 Apr 2025, 2:48PM Global Health Limited has informed the Exchange about Capacity addition
  • Global Health - Outcome of Board Meeting

    28 Apr 2025, 2:44PM Global Health Limited has informed the Exchange regarding Outcome of Board Meeting held on April 28, 2025.
  • Global Health - Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI LODR Regulation

    28 Apr 2025, 3:00PM We wish to inform you that the Board of Directors of the Company, at their meeting held today i.e. Monday, April 28, 2025, have approved the purchase
  • Global Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    28 Apr 2025, 2:51PM This press release is regarding the purchase of land from Assam Electricity Grid Corporation Limited to establish super specialty hospital at Guwahati
  • Global Health - Announcement under Regulation 30 (LODR)-Meeting Updates

    28 Apr 2025, 2:46PM This is regarding purchase of land from Assam Electricity Grid Corporation limited to establish super specialty hospital at Guwahati.
  • Global Health has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    16 Apr 2025, 1:12PM As of March 2025, 33.03% is owned by Indian Promoters and 66.97% by Public. <p align=justify> Institutional holds 23.69% (Insurance Companies 0.69%) a
  • Global Health

    26 Jun 2023 , 12:08PM Global Health or Medanta’s credit rating has been revised to CRISIL AA-/Stable from CRISIL A+/Positive by CRISIL. Positive for the stock.

Key fundamentals

Evaluate the intrinsic value of Global Health Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 3638.05 2907.979 2590.4047 1861.8816 1507.1095
Liabilities 3638.05 2907.979 2590.4047 1861.8816 1507.1095
Equity 53.717 53.701 53.639 50.6448 49.5858
Gross Profit 765.016 497.35 402.2721 374.836 168.4379
Net Profit 461.528 360.891 263.2452 218.784 57.285
Cash From Operating Activities 527.667 340.64 430.5298 235.4034 200.8814
NPM(%) 14.4 15.82 13.43 12.4 4.66
Revenue 3204.146 2280.008 1959.4462 1764.2492 1227.3981
Expenses 2439.13 1782.658 1557.1741 1389.4132 1058.9602
ROE(%) 14.69 11.48 8.37 6.96 1.82

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.5 25 0 1243.3

Peers

Other companies within the same industry or sector that are comparable to Global Health Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
No Records Found

Company Info

Our Company was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by our Shareholders in the EGM held on July 31, 2021 and consequently, the name of our Company was changed to `Global Health Limited' and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e., Investor Selling Shareholder) invested in our Company-1st Joint Commission International ("JCI") accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary, GHPPL, entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital's outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital's inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy 2020 -Global Health listed as a best performing ASX small cap. -Global Health's Lifecard featured in series of Product Snapshots in the Australian healthtech sector. -Global Health joins BP's approved integrator network, goes live with SafeScript 2022 -Global Health is announce that it has secured two significant contracts for Homeless Healthcare (WA) and Peninsula Health (VIC). -Global Health Secures Three Key Contracts with Private Hospitals in NSW and WA. -Global Health brings health management online with new software solutions 2024 -The Company Approved the acquisition of land in Mumbai'by MHADA. -The Ho'nble National Company Law Tribunal, New Delhi Branch, Approved of Merger between MHPL and GHL.

Our Company was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by our Shareholders in the EGM held on July 31, 2021 and consequently, the name of our Company was changed to `Global Health Limited' and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e., Investor Selling Shareholder) invested in our Company-1st Joint Commission International ("JCI") accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary, GHPPL, entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital's outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital's inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy 2020 -Global Health listed as a best performing ASX small cap. -Global Health's Lifecard featured in series of Product Snapshots in the Australian healthtech sector. -Global Health joins BP's approved integrator network, goes live with SafeScript 2022 -Global Health is announce that it has secured two significant contracts for Homeless Healthcare (WA) and Peninsula Health (VIC). -Global Health Secures Three Key Contracts with Private Hospitals in NSW and WA. -Global Health brings health management online with new software solutions 2024 -The Company Approved the acquisition of land in Mumbai'by MHADA. -The Ho'nble National Company Law Tribunal, New Delhi Branch, Approved of Merger between MHPL and GHL.

Read More

Parent Organisation

Global Health Ltd.

Founded

13/08/2004

Managing Director

Dr.Naresh Trehan

NSE Symbol

MEDANTAEQ

FAQ

The current price of Global Health Ltd is ₹ 1343.10.

The 52-week high for Global Health Ltd is ₹ 1348.50 and the 52-week low is ₹ 1330.10.

The market capitalization of Global Health Ltd is currently ₹ 36098.55. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Global Health Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Global Health Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Global Health Ltd shares.

The CEO of Global Health Ltd is Dr.Naresh Trehan, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT